0001014108-20-000108.txt : 20200914
0001014108-20-000108.hdr.sgml : 20200914
20200911174254
ACCESSION NUMBER: 0001014108-20-000108
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200914
DATE AS OF CHANGE: 20200911
EFFECTIVENESS DATE: 20200914
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bond Biosciences, Inc.
CENTRAL INDEX KEY: 0001824224
IRS NUMBER: 810933527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-375370
FILM NUMBER: 201171850
BUSINESS ADDRESS:
STREET 1: 555 MADISON AVENUE
STREET 2: SUITE 1201
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 650-804-2139
MAIL ADDRESS:
STREET 1: 555 MADISON AVENUE
STREET 2: SUITE 1201
CITY: NEW YORK
STATE: NY
ZIP: 10022
D
1
primary_doc.xml
X0708
D
LIVE
0001824224
Bond Biosciences, Inc.
555 MADISON AVENUE
SUITE 1201
NEW YORK
NY
NEW YORK
10022
650-804-2139
DELAWARE
Fetterex Biopharma, Inc.
None
Corporation
true
2015
Michael
A.
Riley
555 Madison Avenue
Suite 1201
New York
NY
NEW YORK
10022
Executive Officer
Director
Timothy
Opler
555 Madison Avenue
Suite 1201
New York
NY
NEW YORK
10022
Director
Cory
Berkland
555 Madison Avenue
Suite 1201
New York
NY
NEW YORK
10022
Director
Other Health Care
Decline to Disclose
- 06b
false
2020-08-31
false
true
true
true
false
0
CIM Securities, LLC
120852
None
None
275 Madison Avenue
39th Floor
New York
NY
NEW YORK
10022
CA
CALIFORNIA
IA
IOWA
KS
KANSAS
MO
MISSOURI
NJ
NEW JERSEY
NY
NEW YORK
ND
NORTH DAKOTA
false
200000
200000
0
false
8
14000
0
0
false
Bond Biosciences, Inc.
/s/Michael A. Riley
Michael A. Riley
Secretary
2020-09-11